Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nichola Cooper

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|November 28, 2023
Safety and efficacy of SARS-CoV-2 vaccination in patients with immune thrombocytopenia: A two-centre reviewSara Stefani, Noora Buti, Alice C J Hart, et al.
British Journal of Haematology|August 18, 2025
Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United StatesNichola Cooper, Caroline Kruse, Sharon Deneen Morgan, et al.
Blood Advances|October 15, 2021
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitroZhi-Jian Liu, Emoke Deschmann, Haley E Ramsey, et al.
Plos One|October 27, 2022
Distorted TCR repertoires define multisystem inflammatory syndrome in childrenAmna Malik, Eszter N Tóth, Michelle S Teng, et al.
The New England Journal of Medicine|September 1, 2021
Mycophenolate Mofetil for First-Line Treatment of Immune ThrombocytopeniaCharlotte A Bradbury, Julie Pell, Quentin Hill, et al.
Therapeutic Advances in Hematology|October 23, 2023
Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III studyDavid J Kuter, James B Bussel, Waleed Ghanima, et al.
American Journal of Hematology|November 28, 2023
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trialNichola Cooper, Waleed Ghanima, Nicola Vianelli, et al.
Blood Advances|September 4, 2020
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopeniaTadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, et al.
Blood|August 5, 2020
Identification of occult cerebral microbleeds in adults with immune thrombocytopeniaNichola Cooper, Melanie A Morrison, Camelia Vladescu, et al.
Plos One|October 15, 2015
Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse ModelMichelle Escobedo-Cousin, Nicola Jackson, Raquel Laza-Briviesca, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|November 28, 2023
Safety and efficacy of SARS-CoV-2 vaccination in patients with immune thrombocytopenia: A two-centre reviewSara Stefani, Noora Buti, Alice C J Hart, et al.
British Journal of Haematology|August 18, 2025
Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United StatesNichola Cooper, Caroline Kruse, Sharon Deneen Morgan, et al.
Blood Advances|October 15, 2021
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitroZhi-Jian Liu, Emoke Deschmann, Haley E Ramsey, et al.
Plos One|October 27, 2022
Distorted TCR repertoires define multisystem inflammatory syndrome in childrenAmna Malik, Eszter N Tóth, Michelle S Teng, et al.
The New England Journal of Medicine|September 1, 2021
Mycophenolate Mofetil for First-Line Treatment of Immune ThrombocytopeniaCharlotte A Bradbury, Julie Pell, Quentin Hill, et al.
Therapeutic Advances in Hematology|October 23, 2023
Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III studyDavid J Kuter, James B Bussel, Waleed Ghanima, et al.
American Journal of Hematology|November 28, 2023
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trialNichola Cooper, Waleed Ghanima, Nicola Vianelli, et al.
Blood Advances|September 4, 2020
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopeniaTadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, et al.
Blood|August 5, 2020
Identification of occult cerebral microbleeds in adults with immune thrombocytopeniaNichola Cooper, Melanie A Morrison, Camelia Vladescu, et al.
Plos One|October 15, 2015
Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse ModelMichelle Escobedo-Cousin, Nicola Jackson, Raquel Laza-Briviesca, et al.
Pageof 15